GI ONCOLOGY

Browse all GI ONCOLOGY
Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

GI ONCOLOGY

Over The Counter Medication: A Game-Changer for PI3K-Altered Colorectal Cancer?

Sawyer Bawek, DO

HEMATOLOGY

Browse all HEMATOLOGY
Year in Review: The Rise of Cellular Immunotherapy for Multiple Myeloma

HEMATOLOGY

Year in Review: The Rise of Cellular Immunotherapy for Multiple Myeloma

Hamza Hashmi, MD

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

HEMATOLOGY

Real-World Evidence Supports Outpatient Axicabtagene Ciloleucel (Yescarta) Administration for Relapsed/Refractory LBCL

Sawyer Bawek, DO

The Impact of Novel Agents in Non-Hodgkin Lymphoma Treatment

HEMATOLOGY

The Impact of Novel Agents in Non-Hodgkin Lymphoma Treatment

Anuja V. Abhyankar, MD

Management of Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory Disease

HEMATOLOGY

Management of Multiple Myeloma: From Newly Diagnosed to Relapsed/Refractory Disease

Vaishali Deenadayalan, MD

LUNG CANCER

Browse all LUNG CANCER
Top Lung Cancer Advances From 2025

LUNG CANCER

Top Lung Cancer Advances From 2025

Chinmay Jani, MD, Ali Al Sbihi, MD, Gilberto Lopes, MD

Ivonescimab Plus Chemotherapy in EGFR+ NSCLC After TKI Therapy

LUNG CANCER

Ivonescimab Plus Chemotherapy in EGFR+ NSCLC After TKI Therapy

Ali Al Sbihi, MD, Chinmay Jani, MD

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

LUNG CANCER

IMforte Trial: A Potential First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Sawyer Bawek, DO

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

LUNG CANCER

Beamion Lung-1: Zongertinib Emerges as a Promising Option in HER2 NSCLC

Sawyer Bawek, DO